David Allan
MD FRCPC
Clinician Scientist, Cancer Research
Ottawa Hospital Research Institute
Professor, Department of Medicine
University of Ottawa
Medical Director, Stem Cells
Canadian Blood Services
Bio
Dr. Allan is a clinician-researcher with the Transplant & Cellular Therapy Program at TOH, the University of Ottawa and in the Cancer Research Program at The Ottawa Hospital Research Institute. He is a graduate of Queen's University and completed residency at the University of Toronto, Western University and transplant training at the Maisonneuve-Rosement Hospital in Montreal.
Research Goals and Interests
News
Publications
New Diagnostic Criteria Can Inflate Myelodysplastic Syndrome Survival Estimates
2026-11-13 Go to publicationRecipient and donor contact following unrelated allogeneic hematopoietic cell transplantation: The Canadian Blood Services' stem cell registry experience
2026-11-11 Go to publicationHow does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?
2026-10-01 Go to publicationA scoping review of gene editing in clinical trials: identifying aspects of trial design to accelerate clinical adoption
2026-10-01 Go to publicationCell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease
2026-09-01 Go to publication